Lei jun biography of alberta

Khitan imperial dynasty of China (916–1125)

The Liao dynasty (;Khitan: Mos Jælud; traditional Chinese: 遼朝; simplified Chinese: 辽朝; pinyin: Liáo cháo), also known as the Khitan State (Mos diau-d kitai huldʒi gur), officially the Great Liao (Chinese: 大遼; pinyin: Dà Liáo), was an imperial dynasty of China that existed between 916 and 1125, ruled by the Yelü clan of the Khitan people. Founded around the time of the collapse of the Tang dynasty, at its greatest extent it ruled over Northeast China, the Mongolian Plateau, the northern part of the Korean Peninsula, southern portions of the Russian Far East, and the northern tip of the North China Plain.

The dynasty rose from the consolidation of power among the Khitans in the 8th century and their expansionist campaigns in the latter half of the 9th century. Eventually the Yila chieftain, Abaoji, became the leader of the Khitans and proclaimed a Chinese-style dynastic state in 916. The Liao dynasty launched multiple military campaigns against neighboring states and peoples including the Kumo Xi, Shiwei, Tatars, Zubu, Khongirad, Balhae, Goryeo, Later Tang, and the Song dynasty. Its conquests include the Sixteen Prefectures (including present-day Beijing and part of Hebei) by fueling a proxy war that led to the collapse of the Later Tang (923–936). In 1004, the Liao launched an expedition against the Northern Song dynasty. After heavy fighting and large casualties between the two empires, both sides worked out the Chanyuan Treaty. Through the treaty, the Liao forced the Northern Song to recognize them as peers and heralded an era of peace and stability between the two powers that lasted approximately 120 years. It was the first state to control all of Manchuria.

Tension between traditional Khitan social and political practices and Han influence and customs was a defining feature of the dynasty. This tensio

Professor Dimitris Petmezas is a Professor of Finance in his second tenure at Durham University Business School as he also held the position of Lecturer in Finance over the period 2005-2007. He has been a Full Professor since the age of 31 and prior to taking up the current position he was a Professor, Reader and Senior Lecturer in Finance at Surrey Business School. Professor Petmezas was also a Visiting Scholar at the University of Chicago Booth School of Business and New York University (NYU) Stern School of Business. He was educated at Aristotle University (BA in Economics) and Durham University (MSc in Finance and Investment with Distinction, and PhD in Finance). He is a Fellow of the Higher Education Academy and a visiting-academic in several European Business Schools teaching in EMBA, MBA and MSc programmes. Additionally, he is an independent M&A advisor. 

Professor Petmezas' main research interests lie in the area of Corporate Finance and, more specifically, in Mergers and Acquisitions (M&As), corporate governance, corporate innovation and ESG. He is also interested in issues related with CEO characteristics, as well as cash holdings, asset sales, financial misconduct, and working capital management (WCM). Professor Petmezas has published extensively in leading international journals including the Journal of Finance, Management Science, Review of Finance, Review of Accounting Studies, Research Policy, andJournal of Corporate Finance. His paper titled “When It Pays to Pay Your Investment Banker: New Evidence on the Role of Financial Advisors in M&As” was the 3rd most-read article in 2012 in the Journal of Finance among all articles that have ever been published in the Journal of Finance. The wide spectrum of his research interests is reflected by his publications in top journals across 5 different fields of business and management studies, such as Finance (Journal of Finance), Accounting (Review of Accounting Studies), Operations

Harnessing extensive scientific knowledge to protect client innovations

An accomplished doctorate recipient, Lei harnesses his advanced knowledge of biotechnology, biological science and chemistry to assist clients with protecting their valuable innovations. Lei makes strides to understand his clients’ business objectives and to obtain intellectual property assets that have business value for them.

Lei drafts and prosecutes Canadian patent applications and coordinates the drafting and prosecution of patent applications worldwide. He counts among his clients pharmaceutical and biotechnology companies, research institutions, and universities. Lei also has experience in IP transactions, and assisting clients with IP due diligence, IP audits and IP–related agreements.

Accomplished medical researcher and award recipient

Lei’s doctoral studies focused on cardiovascular, obesity and atherosclerosis research. During his studies, Lei received multiple prestigious awards including the Merck Frosst Schering Award and the AstraZeneca Award for presentations delivered at the Canadian Lipoprotein Conference, as well as the Dr. Robert John Wilson Fellowship. He also took part in the Stroke, Cardiovascular, Obesity, Lipids, Atherosclerosis Research (SCOLAR) Training Program funded by the Canadian Institutes of Health Research.

Lei has co-authored "Patent Protection for Second Medical Uses: Canada Chapter" (Wolters Kluwer Law, September 26 2016) with Steven Garland and Daniel Davies of Smart Biggar, and "Patent Litigation 2018 – Canada” (Chambers Global Practice Guides, February 2018) with Steven Garland, Jeremy Want and Daniel Davies of Smart Biggar.

Qualifications